Showing 1 - 20 results of 158,288 for search '(( 2 c decrease ) OR ((( 16 _ decrease ) OR ( 5 ((_ decrease) OR (a decrease)) ))))*', query time: 1.85s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

    Published 2019
    “…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
  5. 5
  6. 6

    Decreased Sho levels in ScN2a-Sho cells. by Joel C. Watts (195735)

    Published 2011
    “…(<b>C</b>) Quantification of Sho levels in ScN2a-Sho-1 (<i>n</i> = 10) and ScN2a-Sho-2 (<i>n</i> = 5) subclones revealed a significant decrease of 40–45% compared to the uninfected parental cell line (<i>n</i> = 15) (***<i>P</i><0.001).…”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

    Published 2021
    “…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
  12. 12

    MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

    Published 2014
    “…Statistical analysis was performed using ANOVA (F<sub>3.9</sub> = 5.066, **p<0.01; *p<0.05). (<b>C</b>) PC12 cells transfected with MK-STYX, scrambled shRNA, or MK-STYX shRNA-A. 24 hr post-transfection cells were stimulated with NGF or not, and were lysed 24 hr thereafter and immunoblotted. …”
  13. 13
  14. 14

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Mitochondrial dysfunction is driven by decreased mitochondrial dynamics. by Piero Dalle Pezze (622889)

    Published 2014
    “…(C) Representative live cell images of mitochondrial networks in young (control) and senescent (sen) MRC5 fibroblasts. …”